LifeSiteNews.com

Thursday August 21, 2008



Later Term Abortion on the Rise in France


SHARE: E-mail E-MAIL  Print PRINT     

By Jenna Murphy

PARIS, August 21, 2008 (LifeSiteNews.com) – Post 12-week abortions performed in France, which are only permitted for specific “medical reasons”,  increased by 10% in 2006 with a reported 6,787 compared to 6,093 in 2005.

France’s Biomedical Agency (Agence Biomedicin), which released its 2006 figures on “procreation and human genetic activities” on Wednesday, reported that despite a decline in the number of files reviewed (2.5% less than 2005), the number of requests for ‘interruption of pregnancy for medical reasons’ (IMG) has remained constant since the last report.

In France, abortion is illegal after the 12th week of pregnancy, but a woman can still procure one until the 32nd week if there is evidence of some kind of abnormality. Babies with Down’s syndrome, deformity or fetal abnormalities were victim to 76% of post-twelfth week abortions.  According to l'Agence de la biomedicine, only 2.7% of the abortions were performed in an effort to preserve the health of the mother.

The figures from the report were drawn from 48 multi-disciplinary centers throughout France where physicians perform pre-natal diagnostic testing for various genetic conditions and disease processes. Based on the results of the tests, doctors decide if the baby in question can be aborted. 

Permission was only denied in 1.7% of the cases examined (i.e. those who sought to abort cleft lip babies).

Of the women in France who were given permission to abort, about 6% (402 women in 2006 versus 406 in 2005) decided to continue with their pregnancy.
 
 
To see France’s 2006 IMG figures (in French):
http://www.agence-biomedecine.fr/fr/rapport_2007/pdf/VI_2_tabfig.pdf

Back to Top Back to Top

SHARE: E-mail E-MAIL  Print PRINT     



MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.